Loading organizations...

§ Private Profile · Cambridge, MA, USA
Robigo is a technology company.
Robigo develops advanced crop protection solutions. The company engineers microbes to protect crops from disease, utilizing biomanufacturing, gene editing, and data science to craft effective biological products. These innovations provide alternatives that can outperform synthetic chemistries, enhancing yields and contributing to a resilient global food system.
Andee Wallace is the co-founder and CEO of Robigo, a biotech firm based in Cambridge, Massachusetts. She founded the company with the insight of programming biology for improved food production and sustainable crop treatments. Her scientific background underpins Robigo's approach to agricultural challenges.
Robigo's products serve the agricultural sector by protecting crops from diseases. The company's vision involves leveraging naturally occurring microbes to create targeted solutions that do not harm beneficial microbes, pollinators, or humans. Ultimately, Robigo seeks to foster a food system that is both productive and environmentally sound.
Robigo has raised $8.0M across 2 funding rounds.
Robigo has raised $8.0M in total across 2 funding rounds.
Robigo has raised $8.0M in total across 2 funding rounds.
Robigo's investors include Congruent Ventures, Awesome People Ventures, Banana Capital, Ali Tamaseb, Electric Capital, First Star Ventures, FJ Labs, Gradient Ventures, Infinite Niches, Khosla Ventures, Kleiner Perkins, Paradigm.
Robigo is a biotechnology company founded in 2021 and headquartered in Cambridge, Massachusetts, that develops engineered microbial solutions for crop protection in agriculture.[1][2][3][4] It engineers microbes using tools like CRISPR to target plant pathogens at the genetic level, reducing crop losses from diseases (which affect 20-40% of global crops annually) while minimizing harm to beneficial microbes, pollinators, humans, and the environment—offering a safer alternative to toxic chemical pesticides.[1][2][4] Robigo serves farmers and growers facing untreatable crop diseases, solving the problem of pesticide overuse that damages ecosystems and soil health, with products designed to boost yields, improve soil health, and support sustainable agriculture.[1][2][4] The company has raised approximately $8.28M in total funding, including a $7M seed round, grants from the National Science Foundation, and investments from First Star Ventures, At One Ventures, and others; it employs about 7 people and is scaling toward commercial biopesticide production amid strong grower interest.[1][2][3]
Robigo was co-founded in 2021 by Jai Padmakumar and Andee Wallace, Ph.D., who met as Ph.D. students in the same MIT lab.[2] Padmakumar conceived the core technology during an assignment to engineer microbial communities, while Wallace aimed to apply modern life science tools to make agriculture more sustainable post-graduation.[2] Their friendship and shared vision led to the company's launch in Cambridge, with early focus on using bioengineering and data science for precise crop protection.[1][2][3] Pivotal early moments include securing nondilutive grants (e.g., $700k) targeted at underrepresented founders, including women and minorities, and achieving successful product tests that drew grower interest despite the regulated biopesticide path ahead.[2]
Robigo rides the wave of sustainable agriculture biotech, capitalizing on shifting consumer, grower, and manufacturer preferences toward biopesticides amid climate pressures and pesticide regulations.[2][4] Timing is ideal as global crop losses from pests/diseases hit 20-40% yearly, driving demand for resilient food systems that cut deforestation, emissions, and chemical use.[2][4] Market forces like VC interest in climate tech (e.g., seed funding from At One Ventures) and grants for diverse founders favor Robigo, positioning it to influence the $100B+ crop protection industry by accelerating the shift to microbial alternatives.[1][2] In the tech ecosystem, it exemplifies synbio innovation from MIT roots, contributing to broader trends in precision ag and biodiversity preservation.
Robigo is poised for regulatory milestones, with bioreactor scaling and 4-5 year approvals unlocking commercial biopesticides amid rising biopesticide adoption.[2] Trends like AI-driven bioengineering, climate-resilient farming, and anti-chemical policies will propel growth, potentially expanding to more crops and global markets.[2][4] Its influence may evolve from early-stage innovator to ecosystem shaper, helping farmers boost efficiency and cut emissions—exemplifying how engineered microbes deliver high-impact, low-harm crop protection from day one.[1][2][4]
Robigo has raised $8.0M across 2 funding rounds. Most recently, it raised $7.0M Seed in February 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 1, 2023 | $7M Seed | Congruent Ventures | Awesome People Ventures, Banana Capital, ALI Tamaseb, Electric Capital, First Star Ventures, FJ Labs, Gradient Ventures, Infinite Niches, Khosla Ventures, Kleiner Perkins, Paradigm, Precursor Ventures, Social Capital, Adam D'angelo, Andy Coravos, Anthony Pompliano, Charlie Feng, Dylan Field, JEN Rubio Butterfield, Julia Dewahl, Scott Belsky, Tonio Desorrento, Good Growth Capital | Announced |
| Nov 1, 2021 | $1M Seed | — | Awesome People Ventures, Banana Capital, ALI Tamaseb, Electric Capital, First Star Ventures, FJ Labs, Gradient Ventures, Infinite Niches, Khosla Ventures, Paradigm, Precursor Ventures, Social Capital, Adam D'angelo, Andy Coravos, Anthony Pompliano, Charlie Feng, Dylan Field, JEN Rubio Butterfield, Julia Dewahl, Scott Belsky, Tonio Desorrento, Morningside | Announced |